Integrative approaches continue to improve diagnostic accuracy for pediatric brain cancers, but much more is needed from researchers, governments and regulators if precision medicine with curative treatments are to become a reality.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sturm, D. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02255-1 (2023).
Capper, D. et al. Nature 555, 469–474 (2018).
Louis, D. N. et al. Neuro. Oncol. 23, 1231–1251 (2021).
Gröbner, S. N. et al. Nature 555, 321–327 (2018).
Yeh, J. M. et al. JAMA Oncol. 6, 350–357 (2020).
Wong, M. et al. Nat. Med. 26, 1742–1753 (2020).
van Tilburg, C. M. et al. Cancer Discov. 11, 2764–2779 (2021).
Liu, X. et al. JAMA Netw Open 6, e2251524 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.B. receives grant funding from Novartis Institute of Biomedical Research and has received grant funding from Deerfield Therapeutics, both for unrelated projects. P.B. has also served on a paid advisory board for QED Therapeutics. E.R.M. serves on the supervisory board of Qiagen N.V., the board of directors for Singular Genomics Inc. and a paid advisory board for Scorpion Therapeutics LLC.
Rights and permissions
About this article
Cite this article
Bandopadhayay, P., Mardis, E.R. Accurate diagnosis of pediatric brain cancers. Nat Med 29, 787–788 (2023). https://doi.org/10.1038/s41591-023-02254-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02254-2